Posted inBiotechnology
Superagonist µ-Opioid Analgesic Minimizes Side Effects
A groundbreaking development in pain management has emerged with the discovery of a novel µ-opioid receptor superagonist, named DFNZ, which…
Posted inBiotechnology
Inhibiting MD2 May Prevent Bone Metastasis in Prostate Cancer
A groundbreaking investigation recently published in the prestigious journal Oncoscience casts new light on the molecular underpinnings of prostate cancer…
Posted inBiotechnology
Digital Formulator Powers Fast, Automated Drug Development
In a groundbreaking advancement poised to revolutionize pharmaceutical development, a team of interdisciplinary scientists has introduced a novel platform that…
Posted inBiotechnology
Broadband Nanoprobe Enhances Precision in Optical Imaging
In a groundbreaking advancement that could redefine the frontiers of optical imaging, researchers at Xi’an Jiaotong University have unveiled an…
Posted inBiotechnology
First-in-Class Radio-Theranostic Developed Using Novel Antibody from UT MD Anderson
Researchers at The University of Texas MD Anderson Cancer Center have announced a transformative breakthrough in cancer therapy with the…
Posted inGenetics
Immune Response Gene Variants Tied to Earlier Breast Cancer in BRCA1 Carriers
Scanning electron micrograph of breast cancer cells. [Steve Gschmeissner/Science Photo Library, Getty Images] Researchers headed by a team at Tel…
Posted inGenetics
Biological Complexity of ALS to Be Addressed by the Development of New Stem Cell Models
Degradation of motor neurons, conceptual computer illustration. Motor neuron diseases are a group of neurodegenerative disorders Amyotrophic lateral sclerosis (ALS)…
Posted inGenetics
Cancer Vaccine Design Gets Personal
The landscape of cancer immunotherapies is evolving rapidly. Although peptides or mRNA vaccines encapsulated in lipid nanoparticles are the most…
Posted inGenetics
Spatial Biology
Spatial biology is a rapidly advancing discipline that examines biological molecules (such as DNA, RNA, and proteins) within their native…
Posted inBiotechnology
Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact
After the FDA placed two of its next-gen HIV drugs on clinical hold last June, Gilead Sciences has now terminated…